SE9500418L - Nya försvagade Pseudomonas aerugionos stammar - Google Patents

Nya försvagade Pseudomonas aerugionos stammar

Info

Publication number
SE9500418L
SE9500418L SE9500418A SE9500418A SE9500418L SE 9500418 L SE9500418 L SE 9500418L SE 9500418 A SE9500418 A SE 9500418A SE 9500418 A SE9500418 A SE 9500418A SE 9500418 L SE9500418 L SE 9500418L
Authority
SE
Sweden
Prior art keywords
cfcpa
kccm
pseudomonas aeruginosa
strains
cell wall
Prior art date
Application number
SE9500418A
Other languages
English (en)
Other versions
SE9500418D0 (sv
SE507114C2 (sv
Inventor
Hyun Su Kim
Wan Je Park
Moo Sang Moon
Wang Don Yoo
Kap Soo Noh
Dong Eok Lee
Suk Hoon Ha
Ree An Yoo
Nam Joong Lee
Yang Je Cho
Sun Pyo Hong
Je Hak Kim
Dal Hyun Kim
Young Gi Kim
Original Assignee
Cheil Foods & Chem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019930010281A external-priority patent/KR970001710B1/ko
Priority claimed from KR1019930010273A external-priority patent/KR960014620B1/ko
Application filed by Cheil Foods & Chem filed Critical Cheil Foods & Chem
Publication of SE9500418D0 publication Critical patent/SE9500418D0/sv
Publication of SE9500418L publication Critical patent/SE9500418L/sv
Publication of SE507114C2 publication Critical patent/SE507114C2/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/104Pseudomonadales, e.g. Pseudomonas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
SE9500418A 1993-06-07 1995-02-06 Nya försvagade Pseudomonas aeruginosa stammar SE507114C2 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1019930010281A KR970001710B1 (ko) 1993-06-07 1993-06-07 녹농균 감염증 치료제 및 그의 제조방법
KR1019930010273A KR960014620B1 (ko) 1993-06-07 1993-06-07 신규한 약독화 녹농균 및 그를 이용한 녹농균 감염 예방 백신
PCT/KR1994/000062 WO1994028928A1 (en) 1993-06-07 1994-06-02 Novel attenuated pseudomonas aeruginosa strains

Publications (3)

Publication Number Publication Date
SE9500418D0 SE9500418D0 (sv) 1995-02-06
SE9500418L true SE9500418L (sv) 1995-04-07
SE507114C2 SE507114C2 (sv) 1998-03-30

Family

ID=26629705

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9500418A SE507114C2 (sv) 1993-06-07 1995-02-06 Nya försvagade Pseudomonas aeruginosa stammar

Country Status (16)

Country Link
EP (1) EP0702564B1 (sv)
JP (1) JP2911603B2 (sv)
CN (1) CN1112356A (sv)
AT (1) AT408445B (sv)
AU (1) AU676575B2 (sv)
CA (1) CA2141871C (sv)
CH (1) CH687233A5 (sv)
DE (3) DE4493997T1 (sv)
ES (1) ES2074968B1 (sv)
GB (1) GB2285925B (sv)
NL (1) NL194910C (sv)
NO (1) NO317148B1 (sv)
RU (1) RU2155226C2 (sv)
SE (1) SE507114C2 (sv)
TW (1) TW403655B (sv)
WO (1) WO1994028928A1 (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1086588C (zh) * 1995-12-07 2002-06-26 余国华 假单胞菌活性蛋白及其生产方法
CN1328371C (zh) * 2005-09-01 2007-07-25 北京未名凯拓农业生物技术有限公司 一株铜绿假单胞菌及其培养方法与应用
CN102534027A (zh) * 2012-02-14 2012-07-04 上海中优医药高科技有限公司 MDRPA中QacEΔ1基因的检测引物及其检测方法
CN102534029A (zh) * 2012-02-14 2012-07-04 上海中优医药高科技有限公司 MRSA中QacB基因的检测引物及其检测方法
IT201600091033A1 (it) * 2016-09-08 2018-03-08 Bioimmunizer Sagl Ceppi di batteri probiotici appartenenti al genere Bifidobacterium e loro estratti di cellule probiotiche (ECP) aventi proprietà immunostimolanti.
CN109401992B (zh) * 2017-08-18 2021-07-23 黑龙江省科学院微生物研究所 一株高产内毒素蛋白的铜绿假单胞菌及其应用
CN110724647B (zh) * 2018-07-17 2022-11-04 黑龙江省科学院微生物研究所 一株所产内毒素蛋白对7种血清型菌株具有免疫保护作用的铜绿假单胞菌及其应用
WO2021031270A1 (zh) * 2019-08-22 2021-02-25 四川大学 细菌膜囊泡及其分离制备***和方法
CN114763544A (zh) * 2021-01-15 2022-07-19 黑龙江省科学院微生物研究所 一种铜绿假单胞菌高产蛋白菌株的生物诱变方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928565A (en) * 1971-10-19 1975-12-23 Yuzuru Homma Pharmaceutical preparation of pseudomonas aeruginosa bacterial component possessing anti-tumor and anti-infection properties
US3987164A (en) * 1970-10-20 1976-10-19 Yuzuru Homma Method for prevention of pseudomonas aeruginosa infections
JPS5612435B1 (sv) * 1971-03-29 1981-03-20
DE3829616C2 (de) * 1988-09-01 1996-08-29 Behringwerke Ag Lipoprotein I (OMPI) von Pseudomonas aeruginosa

Also Published As

Publication number Publication date
AU6857194A (en) 1995-01-03
CH687233A5 (de) 1996-10-31
TW403655B (en) 2000-09-01
GB2285925A (en) 1995-08-02
NO950421L (no) 1995-04-07
AT408445B (de) 2001-11-26
ATA900694A (de) 2001-04-15
ES2074968B1 (es) 1996-05-01
AU676575B2 (en) 1997-03-13
RU2155226C2 (ru) 2000-08-27
EP0702564B1 (en) 2000-03-01
EP0702564A1 (en) 1996-03-27
DE4493997T1 (de) 1995-10-05
NL194910C (nl) 2003-07-04
SE9500418D0 (sv) 1995-02-06
DE4447677C2 (de) 1998-07-23
CA2141871A1 (en) 1994-12-22
NO950421D0 (no) 1995-02-06
CA2141871C (en) 1999-05-11
SE507114C2 (sv) 1998-03-30
ES2074968A1 (es) 1995-09-16
NL194910B (nl) 2003-03-03
GB2285925B (en) 1997-04-09
GB9502373D0 (en) 1995-03-29
NO317148B1 (no) 2004-08-30
NL9420005A (nl) 1995-06-01
DE4493997C2 (de) 1997-07-17
WO1994028928A1 (en) 1994-12-22
JPH09501826A (ja) 1997-02-25
JP2911603B2 (ja) 1999-06-23
CN1112356A (zh) 1995-11-22

Similar Documents

Publication Publication Date Title
EP0129147B1 (en) High titer pseudomonas immune serum globulin and method of making same
NO20002413L (no) Antistoffer mot Moraxella proteiner og anvendelse derav, samt sett for pÕvisning av antigen og farmasøytisk preparat som inneholder antistoffer
RU95105518A (ru) Применение мутантов вируса герпеса, вакцина
GB9224584D0 (en) Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
ITFI920052A1 (it) Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico.
EP0068660A1 (en) Protection against dental caries
SE9500418L (sv) Nya försvagade Pseudomonas aerugionos stammar
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
US4203971A (en) Neisseria gonorrhoeae vaccine
JP2534470B2 (ja) 免疫グロブリンg含有製剤及びその製造方法
Anwar et al. Antibody response to acute Pseudomonas aeruginosa infection in a burn wound
RU94045907A (ru) Вич-антитела человека или их фрагменты, экспрессионные кассеты, клетки-хозяева, фармацевтические композиции, способ защиты
Seed Trypanosoma gambiense and T. equiperdum: Characterization of variant specific antigens
Ayakawa et al. Heart cross-reactive antigens of mutans streptococci share epitopes with group A streptococci and myosin.
FR2736064B1 (fr) Epitopes protecteurs de l'adenyl cyclase-hemolysine(ac-hty). leur application au traitement ou a la prevention des infections par bordetella
Pennington Pseudomonas aeruginosa: vaccines and immunotherapy
AU2667600A (en) Identification of specific differentially expressed antigens
ATE256745T1 (de) Therapeutischer- und präventivimpfstoff gegen hiv
CA1302882C (en) Vaccines and immunoglobulin g-containing preparations active against pseudomonas aeruginosa
Spickett et al. Sweating sickness: relative curative effect of hyperimmune serum and a precipitated immunoglobulin suspension and immunoblot identifiation of proposed immunodominant tick salivary gland proteins
KR950000159A (ko) 녹농균 감염증 치료제 및 예방 백신을 제조하기 위한 약독화 녹농균주 cfcpa 30720의 용도
Mukerjee et al. Effect of adjuvants on immunization with dengue virus-induced cytotoxic factor
RU2035189C1 (ru) Способ получения ассоциированной вакцины для профилактики инфекций, вызываемых условно-патогенными бактериями
KR950000164A (ko) 녹농균 감염증 치료제 및 그의 제조방법
KR950000157A (ko) 녹농균 감염증 치료제 및 예방 백신을 제조하기 위한 약독화 녹농균주 cfcpa 10142의 용도

Legal Events

Date Code Title Description
NUG Patent has lapsed